Using the selected mouse monoclonal antibody 33B7 to carry out immunoprecipitation, followed by mass spectrometry analysis, our laboratory has identified Prostaglandin F2 Receptor Negative Regulator (PTGFRN) as an internalizable cell-surface target expressed on several cancer cells. Here, PTGFRN is linked to cancer.